Clinical trials

  • BI 1015550 (chemical: 1-[[(5R)-2-[4-(5-CHLORO-2-PYRIMIDINYL)-1-PIPERIDINYL]-6,7-DIHYDRO-5-OXIDOTHIENO[3,2-D]PYRIMIDIN-4-YL]AMINO]-CYCLOBUTANEMETHANOL) for Idiopathic pulmonary fibrosis | Progressive pulmonary fibrosis
  • (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE for ER-positive breast cancer
  • RAXTOZINAMERAN for Type 1 diabetes | Islet autoimmunity
  • VANCOMYCIN HYDROCHLORIDE for Infectious disease
  • COPPER SULPHATE, ANHYDROUS; STANNOUS CHLORIDE DIHYDRATE; ZINC CHLORIDE; COBALT CHLORIDE; GOLD SODIUM THIOSULFATE; SODIUM TETRACHLOROPALLADATE; VANADIUM OXIDE SULFATE; AMMONIUM TITANIUM OXALATE MONOHYDRATE; NICKEL SULFATE; MANGANESE CHLORIDE TETRAHYDRATE; KALIUM BICHROMICUM for Allergic contact dermatitis|Eczema
  • Pentixather; Yttrium-90 for Non-Hodgkin lymphoma
  • PERMETHRIN for Scabies
  • PEMBROLIZUMAB for Resectable soft tissue sarcoma
  • RALUDOTATUG DERUXTECAN for Platinum-resistant high-grade serous ovarian cancer | High-grade endometrioid ovarian cancer | Primary peritoneal cancer | Fallopian tube cancer
  • DAPAGLIFLOZIN for Kidney transplantation
  • LINVOSELTAMAB for Relapsed or refractory systemic light-chain (AL) amyloidosis | Systemic light-chain (AL) amyloidosis
  • AUTOLOGOUS PANCREATIC ISLETS for Periampullary carcinoma|Pancreatic cancer